Article
The COVID-19 pandemic: viral variants and vaccine efficacy
1 Oct 2021
Abstract excerpt
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has prompted the scientific community and the pharmaceutical companies to put maximum efforts into developing vaccines to contain the spread of this disease. Presently, many vaccines have been developed and authorized for use in human beings in different countries. In particular, in Europe to date, the Pfizer-BioNTech, Moderna, AstraZeneca...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
